Paper
Development of postbiotics by whey bioconversion with Enterococcus faecalis M157 KACC81148BP and Lactococcus lactis CAU2013 KACC81152BP for treating periodontal disease and improving gut health.
Summary
What the paper reports, in its own words.
Abstract
This study developed postbiotics with whey bioconversion product produced by Enterococcus faecalis M157 KACC 81148BP, and mixed whey bioconversion products produced by E. faecalis M157 KACC 81148BP and Lactococcus lactis ssp. lactis CAU2013 KACC 81152BP to alleviate periodontitis (PD) and to improve gut health. The powdered whey bioconversion product (EF) produced by E. faecalis M157 KACC 81148BP, mixed whey bioconversion products (EF+LL) from E. faecalis M157 KACC 81148BP and L. lactis CAU2013 KACC 81152BP, and phosphate-buffered saline (PBS; control) were administered orally to PD-induced rats for 8 wk. Infiltration of inflammatory cells and epithelial proliferation in periodontal tissue were found in control, but the lesions were reduced in PD+EF group (administration of EF to PD-induced rats), and no lesions were observed in PD+EF+LL group (administration of EF+LL to PD-induced rats). The bone loss volumes in PD+EF and PD+EF+LL groups were lower than in control. Cytokine production levels related to inflammation were lower and antioxidative stress markers were higher in PD+EF and PD+EF+LL groups than in control for both periodontal tissue and gut. The ratios of Lactobacillus spp. in gut microbiome of PD+EF and PD+EF+LL groups were higher than in control. These results indicate that the whey bioconversion product produced by E. faecalis M157 KACC 81148BP, and mixed whey bioconversion products produced by E. faecalis M157 KACC 81148BP and L. lactis CAU2013 KACC 81152BP are effective on relieving periodontitis and improving the gut health.
AI summary
90% confidenceMES research in bioelectrochemical. This study developed postbiotics with whey bioconversion product produced by Enterococcus faecalis M...
Generated by MESSAI extraction pipeline · review against source PDF
Extracted values
Every value pulled from the paper, with its source, so each number can be checked against the text.
Methodology
What was the system and how was it run
Methodology
Methodology
The study involved administering powdered whey bioconversion products produced by Enterococcus faecalis and Lactococcus lactis to periodontitis-induced rats for 8 weeks to assess their effects on periodontal disease and gut health.
Performance metrics
| Field | Value |
|---|---|
| citation count | 16 |
Pipeline
Raw extractions, artifacts, quality signal
Extraction quality
honesty signalCalibrate your trust in the extracted content against these signals — they're how the pipeline rated its own output for this paper.
Parameter completeness
13%
Fraction of expected parameters extracted
Data completeness
40%
Overall extraction coverage across fields
AI confidence
90%
Model self-reported confidence
review against source PDF before citing · scores 0–1
Chart explorer
Move the inputs this paper used and see how the predicted outcome shifts.
Explore model
The reactor in 3D, with flow you can switch on and off.
AI insights
Contradictions, gaps and opportunities found by comparing this paper with the corpus.
Compare similar papers
The nearest papers by system, materials and organisms, with their outcomes side by side.
Source PDF
The paper as published.
No 3D model is mapped to this paper yet. The values extracted from it are listed under Extracted values.
In this record
Organisms, parameters and materials this paper reports. Each links to its page.
Organisms · 1
Keywords
- Bioconversion
- Enterococcus faecalis
- Microbiology
- Lactococcus lactis
- Food science
Cite
E. Park, J. Ha, S. Lim et al. (2021). Development of postbiotics by whey bioconversion with Enterococcus faecalis M157 KACC81148BP and Lactococcus lactis CAU2013 KACC81152BP for treating periodontal disease and improving gut health. Journal of Dairy Science. https://doi.org/10.3168/jds.2021-20616
- Journal
- Journal of Dairy Science